Cocaine Use Disorders Clinical Trial
Official title:
D-Cycloserine Facilitation of Cocaine - Cue Extinction
The purpose of this study is to explore the use of d-cycloserine (DCS) to facilitate extinction of response to cocaine cues in cocaine-dependent individuals, in hopes that it may lead to the development of new treatment options for cocaine dependence.
Cocaine dependence remains a serious problem in the United States today and in spite of two decades of intense research, efficacious pharmacotherapeutic treatments have not been identified. Cocaine-associated environmental cues can elicit drug craving and exposure to cocaine-related cues is likely to be involved in relapse. Emerging data supports the role of glutamate in extinction learning. D-cycloserine (DCS), a partial glutamate agonist, facilitates extinction of associative learning in animal models of fear-conditioning and clinical studies of exposure treatment for anxiety disorders. A recent study demonstrated DCS acceleration of extinction of cocaine-induced conditioned place preference in rats (Botreau et al., 2006). Exploration of DCS in facilitating extinction of response to drug-related cues in humans is needed. The proposed study will extend these innovative and promising findings from the basic science arena and anxiety disorders field in a proof of concept investigation of DCS facilitation of extinction of response to cocaine-related cues in a human laboratory paradigm. In addition, to examine the neural substrates of extinction learning, a sub-set of individuals that are willing and eligible will undergo fMRI scanning procedures before and after the extinction protocol. ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01639157 -
Impact of Buspirone Maintenance on the Reinforcing Effects of Cocaine
|
N/A | |
Completed |
NCT00780442 -
D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals
|
Phase 2 | |
Completed |
NCT00178776 -
A Transtheoretical Model Group Therapy for Cocaine
|
Phase 1 | |
Recruiting |
NCT02680288 -
Lorcaserin Intra Venous Cocaine Effects
|
Phase 1/Phase 2 | |
Completed |
NCT02909101 -
Project IMPACT: Improving Memory Performance by Applying Cognitive Training
|
N/A | |
Completed |
NCT01739192 -
A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
|
Early Phase 1 | |
Completed |
NCT01495195 -
Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior
|
Phase 2 | |
Completed |
NCT02373124 -
Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial
|
Phase 1/Phase 2 |